IGDCC3 and sarcoma: By analyzing the results of the drug‐gene interaction network and DEG analysis results, we found that rilmenidine can exert a drug effect in sarcomas by interacting with the immunoglobulin superfamily DCC subclass member 3 (IGDCC3) gene.